These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Vaccinia virus Western Reserve induces rapid surface expression of a host molecule detected by the antibody 4C7 that is distinct from CLEC2D. Williams KJ; Eaton HE; Jones L; Rengan S; Burshtyn DN Microbiol Immunol; 2016 Nov; 60(11):754-769. PubMed ID: 27862195 [TBL] [Abstract][Full Text] [Related]
25. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells. McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818 [TBL] [Abstract][Full Text] [Related]
27. M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells. Liu J; Wennier S; Zhang L; McFadden G J Virol; 2011 Apr; 85(7):3270-82. PubMed ID: 21248034 [TBL] [Abstract][Full Text] [Related]
29. Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways. Rahman MM; McFadden G Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32456120 [TBL] [Abstract][Full Text] [Related]
30. Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin. Lun X; Alain T; Zemp FJ; Zhou H; Rahman MM; Hamilton MG; McFadden G; Bell J; Senger DL; Forsyth PA Cancer Res; 2010 Jan; 70(2):598-608. PubMed ID: 20068158 [TBL] [Abstract][Full Text] [Related]
31. Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor. Lilly CL; Villa NY; Lemos de Matos A; Ali HM; Dhillon JS; Hofland T; Rahman MM; Chan W; Bogen B; Cogle C; McFadden G Mol Ther Oncolytics; 2017 Mar; 4():31-40. PubMed ID: 28345022 [TBL] [Abstract][Full Text] [Related]
32. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits. Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL Viruses; 2020 May; 12(5):. PubMed ID: 32397134 [TBL] [Abstract][Full Text] [Related]
33. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection. Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309 [TBL] [Abstract][Full Text] [Related]
34. Vaccinia Virus A6 Is a Two-Domain Protein Requiring a Cognate N-Terminal Domain for Full Viral Membrane Assembly Activity. Meng X; Rose L; Han Y; Deng J; Xiang Y J Virol; 2017 May; 91(10):. PubMed ID: 28275183 [TBL] [Abstract][Full Text] [Related]
35. MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection. Blanié S; Gelfi J; Bertagnoli S; Camus-Bouclainville C Virol J; 2010 Mar; 7():56. PubMed ID: 20211013 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological manipulation of the akt signaling pathway regulates myxoma virus replication and tropism in human cancer cells. Werden SJ; McFadden G J Virol; 2010 Apr; 84(7):3287-302. PubMed ID: 20106927 [TBL] [Abstract][Full Text] [Related]
37. In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strains. Pignolet B; Duteyrat JL; Allemandou A; Gelfi J; Foucras G; Bertagnoli S Virol J; 2007 Sep; 4():94. PubMed ID: 17900332 [TBL] [Abstract][Full Text] [Related]
38. Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus. Bartee E; Chan WM; Moreb JS; Cogle CR; McFadden G Biol Blood Marrow Transplant; 2012 Oct; 18(10):1540-51. PubMed ID: 22516053 [TBL] [Abstract][Full Text] [Related]
39. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Stanford MM; McFadden G Expert Opin Biol Ther; 2007 Sep; 7(9):1415-25. PubMed ID: 17727330 [TBL] [Abstract][Full Text] [Related]
40. Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virus. Weng M; Zhang M; Qin Y; Gong W; Tang Z; Quan Z; Wu K Chin Med J (Engl); 2014; 127(12):2350-6. PubMed ID: 24931255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]